Insider Transactions in Q4 2020 at Acceleron Pharma Inc (XLRN)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2020
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
42,528
-79.13%
|
$5,528,640
$130.14 P/Share
|
|
Dec 14
2020
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,528
+22.09%
|
$1,445,952
$34.99 P/Share
|
|
Dec 11
2020
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
3,100
-21.65%
|
$387,500
$125.0 P/Share
|
|
Dec 11
2020
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,100
+17.8%
|
$127,100
$41.2 P/Share
|
|
Dec 10
2020
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
500
-4.27%
|
$62,500
$125.12 P/Share
|
|
Dec 10
2020
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.07%
|
$17,000
$34.99 P/Share
|
|
Dec 09
2020
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
3,872
-25.66%
|
$484,000
$125.03 P/Share
|
|
Dec 09
2020
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,872
+6.51%
|
$131,648
$34.99 P/Share
|
|
Oct 12
2020
|
Terrence C Kearney Director |
SELL
Open market or private sale
|
Direct |
37,500
-34.52%
|
$4,462,500
$119.32 P/Share
|
|
Oct 12
2020
|
Terrence C Kearney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+27.15%
|
$1,050,000
$28.84 P/Share
|